Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alcobra Ltd (NASDAQ:ADHD)

4.87
Delayed Data
As of May 23
 +0.27 / +5.87%
Today’s Change
3.15
Today|||52-Week Range
9.50
-22.45%
Year-to-Date

Today’s Trading

Previous close4.60
Today’s open4.60
Day’s range4.55 - 4.95
Volume187,928
Average volume (3 months)114,076
Market cap$126.8M
Dividend yield--
Data as of 05/23/2016

Growth & Valuation

Earnings growth (last year)+62.50%
Earnings growth (this year)-0.89%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book1.83

Competitors

 Today’s
change
Today’s
% change
TTNPTitan Pharmaceutical...+0.52+8.20%
NEOSNeos Therapeutics In...-0.27-3.45%
ADMPAdamis Pharmaceutica...+0.01+0.12%
STMLStemline Therapeutic...-0.06-0.94%
Data as of 05/23/2016

Financials

Last reporting dateMay 16, 2016
EPS forecast (this quarter)-$0.22
Annual revenue (last year)$0.00
Annual profit (last year)-$19.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Yaron Daniely
Chief Operating &
Financial Officer
Tomer Berkovitz
Corporate headquarters
Tel Aviv, Tel Aviv

Forecasts

Partner Offers

Search for Jobs